Abstract:Abstract Disclosure: S.S. Alfadl: None. A.A. Asiri: None. A.A. Jammah: None. O. Alsagheir: None. Introduction: Graves’ ophthalmopathy is an autoimmune disorder that affects the eyes, characterized by swelling, proptosis, lid lag, inflammation and eyelid retraction. A significant proportion of cases are associated with thyrotoxicosis and positive serum TSH receptor antibody tests. Case Description: We present a case series of euthyroid Graves’ ophthalmopathy in patients with a negative TSH receptor antibody. The first case is of a 37-year-old lady who was recently diagnosed with idiopathic intracranial hypertension due to history of recurrent headaches and was found on CT brain to have an incidental empty sella syndrome and findings highly suggestive of thyroid associated orbitopathy. A dedicated MRI orbit showed bilateral mild proptosis with bilateral medial and inferior recti thickening, sparing the tendinous insertion. The involved extraocular muscles show mild peripheral high T2 signals and minimal enhancement on post gadolinium images. The enlarged extraocular muscle demonstrates diffusion restriction with low Apparent Diffusion Coefficient (ADC) value. Clinically, the patient did not exhibit any symptoms of hyperthyroidism or hypothyroidism. She did not notice any changes in her eyes’ appearance, nor any changes in vision or double vision. On examination, she had mild proptosis, no restriction of extraocular movement or provoked double vision. Consequently, she was referred to Ophthalmology for further management. Investigations included a pituitary panel which did not reveal any abnormalities and a thyroid panel which revealed that she was biochemically euthyroid with a negative TSH receptor antibody test. The second case is of a 24-year-old male who is medically free and initially visited the ophthalmology clinic complaining of double vision, without any additional ophthalmic complaints. He was subsequently referred to our care to rule out thyroid eye disease. Clinically, the patient had no indications of thyroid dysfunction. Upon examination, he exhibited severe right eye proptosis with dystopia and early left eye proptosis. CT orbit showed swelling of the right-sided superior rectus, medial rectus, lateral rectus and left-sided superior rectus muscles. The left-sided superior rectus muscle was abutting the optic nerve. Nevertheless, all tendons were spared. Biochemically, he was euthyroid with unremarkable laboratory results. Conclusion: These findings provide insight into the clinical presentation of euthyroid Graves’ ophthalmopathy in patients without thyrotoxicosis or detectable circulating levels of TSH receptor antibodies. Thus, suggesting that thyroid ophthalmopathy might present earlier than Graves’ disease and even earlier than the presence of TSH receptor antibodies. We conclude that a high index of suspicion and proper follow up is recommended in similar patients for the development of Graves’s disease. Presentation: Thursday, June 15, 2023

A Pair-Matched Comparison and Follow-up Study of Patients with Euthytroid Graves Ophthalmopathy and Patients with Hyperthyroid Graves Ophthalmopathy

Prevalence and Significance of Antibodies Reactive with Eye Muscle Membrane Antigens in Sera from Patients with Graves' Ophthalmopathy and Other Thyroid and Nonthyroid Diseases

Euthyroid graves' ophthalmopathy in a Chinese population: A cross-sectional follow-up study

Ocular surface and meibomian gland evaluation in euthyroid Graves' ophthalmopathy

Temporal trends in the clinical presentation of Graves’ orbitopathy: a single–center retrospective study

Interaction of surfactants with thickeners used in waterborne paints: a rheological study.

THU668 Euthyroid Graves’ Ophthalmopathy: Case Series

Comparison of Early Total Thyroidectomy with Antithyroid Treatment in Patients with Moderate-Severe Graves' Orbitopathy: A Randomized Prospective Trial

Path-integral quantum cosmology. I. Vacuum Bianchi type I.

Treatment Modalities for Graves' Ophthalmopathy

Clinical Study on Thyroid-associated Immune Exophthalmos Treated by compound anisodine Combined with Shihu Xiaolei Pills

Retraction: Efficacy and safety of tripterygium glycosides for active moderate to severe Graves' ophthalmopathy: a randomised, observer-masked, single-centre trial.

Recent Advances in Graves Ophthalmopathy Medical Therapy: a Comprehensive Literature Review.

Long-term outcomes of inferomedial orbital wall decompression in Graves’ ophthalmopathy in an Asian population: A 30-year retrospective study

Association of thyroid-stimulating antibody with the clinical characteristics of Graves' ophthalmopathy

Therapeutic Outcomes of Mycophenolate Mofetil and Three Other Immunosuppressants in Patients with Graves’ Ophthalmopathy

The association between 8-hydroxy-deoxyguanosine and Graves' ophthalmopathy

The Relationship between Obesity-Related Factors and Graves' Orbitopathy: A Pilot Study

ESR evidence of attenuation of hydroxyl radical generation in rat cerebral ischemia-reperfusion model by oxypurinol.

Application of Magnetic Resonance Imaging in the Evaluation of Disease Activity in Graves’ Ophthalmopathy

Immunosuppressive therapies in patients with Graves' ophthalmopathy]